Dechert Report Finds Robust Growth in NJ Securities Class Actions
The volume of securities fraud suits against life sciences companies set a nationwide record in 2017, and New Jersey is emerging as a leading venue for such cases, according to a report issued by Dechert.
February 14, 2018 at 04:31 PM
5 minute read
Photo Credit: Diego M. Radzinschi/ALM
The volume of securities fraud suits against life sciences companies set a nationwide record in 2017, and New Jersey is emerging as a leading venue for such cases, according to a report issued by Dechert.
Nationwide, plaintiffs filed 88 class action securities lawsuits against life sciences companies in 2017, an increase of more than 30 percent from the 67 suits filed in the previous year, and an increase of more than 225 percent from five years prior.
The growth in suits against life sciences companies mirrors a general uptick in securities class actions—412 suits were filed nationwide in 2017, up from 270 in 2016 and 188 in 2015, said the report, issued Tuesday.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250